MARKET

CDTX

CDTX

Cidara Theraptcs
NASDAQ
0.9200
+0.0779
+9.25%
Closed 16:00 03/28 EDT
OPEN
0.8600
PREV CLOSE
0.8421
HIGH
0.9585
LOW
0.8600
VOLUME
1.47M
TURNOVER
0
52 WEEK HIGH
1.480
52 WEEK LOW
0.5930
MARKET CAP
83.37M
P/E (TTM)
-2.3675
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CDTX last week (0318-0322)?
Weekly Report · 3d ago
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 03/21 21:30
Weekly Report: what happened at CDTX last week (0311-0315)?
Weekly Report · 03/18 10:26
Weekly Report: what happened at CDTX last week (0304-0308)?
Weekly Report · 03/11 10:24
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 03/06 22:55
Weekly Report: what happened at CDTX last week (0226-0301)?
Weekly Report · 03/04 10:26
Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates
NASDAQ · 02/28 23:50
Weekly Report: what happened at CDTX last week (0219-0223)?
Weekly Report · 02/26 10:34
More
About CDTX
Cidara Therapeutics, Inc. is a biotechnology company. The Company is focused on the discovery, development and commercialization of therapeutics designed for patients facing serious diseases. The Company's lead product candidate is rezafungin acetate, an intravenous formulation of an echinocandin. Rezafungin is being developed as a once-weekly, high-exposure therapy for the treatment and prevention of serious invasive fungal infections. The Company’s primary focus is using its Cloudbreak platform to develop a potential new class of drugs called drug-Fc conjugates (DFCs), for the prevention and treatment of serious diseases. This technology couples’ potent inhibitors to a human antibody fragment to create long-acting DFCs designed to inhibit multiple disease targets. Its advanced DFC program is CD388, a long-acting antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase I and Phase IIa clinical trials.

Webull offers Cidara Therapeutics Inc stock information, including NASDAQ: CDTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDTX stock methods without spending real money on the virtual paper trading platform.